In a similar model, a global deletion of TLR4 attenuated the post-inflammatory allodynia in males, whereas an intrathecal injection of a TLR4 antagonist given during the inflammatory phase fully reversed the pain-like behavior associated with arthritis in males [209]. The gene discussed is TLR4; the disease is arthritic joint disease.